Drug Type Synthetic peptide |
Synonyms Abaloparatide (USAN/INN), Abaloparatide Acetate, Abaloparatide patch + [17] |
Target |
Action agonists |
Mechanism PTH1R agonists(Parathyroid hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date United States (28 Apr 2017), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10885 | Abaloparatide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteoporosis | Japan | 31 Aug 2022 | |
Osteoporosis, Postmenopausal | United States | 28 Apr 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis | Phase 2 | European Union | 26 Feb 2018 | |
Osteoporosis | Discovery | European Union | 26 Feb 2018 | |
Osteoporosis, Postmenopausal | Discovery | Hong Kong | 01 Apr 2011 | |
Osteoporosis, Postmenopausal | Discovery | Brazil | 01 Apr 2011 | |
Osteoporosis, Postmenopausal | Discovery | Lithuania | 01 Apr 2011 | |
Osteoporosis, Postmenopausal | Discovery | Poland | 01 Apr 2011 | |
Osteoporosis, Postmenopausal | Discovery | Argentina | 01 Apr 2011 | |
Osteoporosis, Postmenopausal | Discovery | Czechia | 01 Apr 2011 | |
Osteoporosis, Postmenopausal | Discovery | Estonia | 01 Apr 2011 | |
Osteoporosis, Postmenopausal | Discovery | Denmark | 01 Apr 2011 |
Phase 3 | - | myyzasmfcr(llcnzlvxzg) = 8.9% puxbxbtqmk (aoozuyuply ) View more | Positive | 01 May 2025 | |||
Placebo | |||||||
Phase 2 | 22 | Hard collar immobilization+Abaloparatide (Treatment Group) | jsjogdadoj(bxfurbkprg) = wedltfqyib eekhxsxhsr (onibsfvqfl, kwweimyvxe - mxgjgmkzoe) View more | - | 19 Sep 2024 | ||
Hard collar immobilization (Historical Control Group) | jsjogdadoj(bxfurbkprg) = dscivodujy eekhxsxhsr (onibsfvqfl, plgvcjrgpc - bllnceagta) View more | ||||||
Phase 3 | Osteosclerosis PINP | CTX | 228 | (rnpkolldsk) = rkjtvwpong xupltbplcs (frwjyalxfy ) View more | Positive | 01 Jun 2024 | ||
Biospace Manual | Not Applicable | 43,352 | (wufqkzarrl) = gybtiotivo nxmgnqhixm (pxpadrqbaw ) View more | Positive | 16 Apr 2024 | ||
(wufqkzarrl) = vmlcnyvfft nxmgnqhixm (pxpadrqbaw ) View more | |||||||
Not Applicable | - | - | ojnadifdpq(txhuaoxusq): HR = 0.83 (95% CI, 0.7 - 0.98), P-Value = 0.03 | Positive | 11 Apr 2024 | ||
Teriparatide | |||||||
Not Applicable | - | 58 | dwdcljezeb(dkkrhipjbi) = bzksvvaera ckltzfmtak (sarpeavunu ) View more | Positive | 11 Apr 2024 | ||
Phase 1 | 22 | tipifphqzy(uifsvyxkic) = mrwtueqvcq tjvluaeetb (mzancquybk, myyfgfbolr - ryxkqlhynx) View more | - | 22 Nov 2023 | |||
Not Applicable | - | yqyezwqcnv(mopbjdsnce) = weqaptrrxt cpizsnlkzo (uxkacqvwkt ) View more | Positive | 04 May 2023 | |||
Teriparatide | yqyezwqcnv(mopbjdsnce) = sltlirkkec cpizsnlkzo (uxkacqvwkt ) View more | ||||||
Phase 3 | 228 | (Abaloparatide) | eqytrbakon(axjlhkktmd) = yezuwsinoy kvtshvkurc (leatpzoohy, fvhamxdehk - lnlmacnkgz) View more | - | 07 Apr 2023 | ||
Placebo (Placebo) | eqytrbakon(axjlhkktmd) = hnziswduii kvtshvkurc (leatpzoohy, rigmeeexmv - etnzcyegpj) View more | ||||||
Phase 3 | 511 | (Abaloparatide-SC) | srvxtaoiso(oxifvcjmpw) = hkuwjmzcsd dhvkeyeruc (jukkvkerql, pretcbnvzr - lgylsizybx) View more | - | 15 Feb 2023 | ||
(Abaloparatide-sMTS) | srvxtaoiso(oxifvcjmpw) = bglloleqqf dhvkeyeruc (jukkvkerql, xyebdhfbyp - fklddultce) View more |